Advanced Medical Solutions Group Future Growth
Future criteria checks 4/6
Advanced Medical Solutions Group is forecast to grow earnings and revenue by 20.8% and 14.1% per annum respectively. EPS is expected to grow by 18.4% per annum. Return on equity is forecast to be 10.2% in 3 years.
Key information
20.8%
Earnings growth rate
18.4%
EPS growth rate
| Medical Equipment earnings growth | 20.1% |
| Revenue growth rate | 14.1% |
| Future return on equity | 10.2% |
| Analyst coverage | Good |
| Last updated | 16 Jan 2025 |
Recent future growth updates
Recent updates
Investors Could Be Concerned With Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
Jan 15
Advanced Medical Solutions Group plc's (LON:AMS) Popularity With Investors Is Under Threat From Overpricing
Nov 18A Look At The Fair Value Of Advanced Medical Solutions Group plc (LON:AMS)
Sep 07Should You Be Adding Advanced Medical Solutions Group (LON:AMS) To Your Watchlist Today?
Nov 03Advanced Medical Solutions Group plc (LON:AMS) Shares Could Be 38% Below Their Intrinsic Value Estimate
Sep 05Advanced Medical Solutions Group (LON:AMS) Will Want To Turn Around Its Return Trends
Dec 03Are Investors Undervaluing Advanced Medical Solutions Group plc (LON:AMS) By 23%?
Sep 03Advanced Medical Solutions Group's (LON:AMS) Returns On Capital Not Reflecting Well On The Business
Aug 05An Intrinsic Calculation For Advanced Medical Solutions Group plc (LON:AMS) Suggests It's 33% Undervalued
May 31Advanced Medical Solutions Group (LON:AMS) May Have Issues Allocating Its Capital
Apr 23Advanced Medical Solutions Group (LON:AMS) Might Be Having Difficulty Using Its Capital Effectively
Jan 08A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Nov 24Some Investors May Be Worried About Advanced Medical Solutions Group's (LON:AMS) Returns On Capital
May 22A Look At The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Apr 10Results: Advanced Medical Solutions Group plc Exceeded Expectations And The Consensus Has Updated Its Estimates
Mar 20Should Advanced Medical Solutions Group (LON:AMS) Be Disappointed With Their 30% Profit?
Feb 28The Returns At Advanced Medical Solutions Group (LON:AMS) Provide Us With Signs Of What's To Come
Feb 07
Advanced Medical Solutions Group plc's (LON:AMS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?
Jan 18How Much Is Advanced Medical Solutions Group plc (LON:AMS) Paying Its CEO?
Dec 28Calculating The Intrinsic Value Of Advanced Medical Solutions Group plc (LON:AMS)
Dec 10The Advanced Medical Solutions Group (LON:AMS) Share Price Is Up 38% And Shareholders Are Holding On
Nov 20Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2027 | 254 | N/A | N/A | N/A | 1 |
| 12/31/2026 | 244 | 17 | 21 | 37 | 8 |
| 12/31/2025 | 229 | 17 | 24 | 35 | 8 |
| 12/31/2024 | 178 | 10 | 16 | 22 | 7 |
| 6/30/2024 | 131 | 11 | 6 | 15 | N/A |
| 3/31/2024 | 129 | 14 | 4 | 14 | N/A |
| 12/31/2023 | 126 | 16 | 2 | 12 | N/A |
| 9/30/2023 | 128 | 18 | 5 | 15 | N/A |
| 6/30/2023 | 129 | 20 | 8 | 18 | N/A |
| 3/31/2023 | 127 | 20 | 12 | 23 | N/A |
| 12/31/2022 | 124 | 20 | 17 | 27 | N/A |
| 9/30/2022 | 121 | 19 | 19 | 28 | N/A |
| 6/30/2022 | 117 | 18 | 22 | 30 | N/A |
| 3/31/2022 | 113 | 18 | 23 | 30 | N/A |
| 12/31/2021 | 109 | 17 | 25 | 31 | N/A |
| 9/30/2021 | 103 | 16 | 23 | 29 | N/A |
| 6/30/2021 | 98 | 14 | 21 | 26 | N/A |
| 3/31/2021 | 92 | 11 | 18 | 24 | N/A |
| 12/31/2020 | 87 | 9 | 16 | 22 | N/A |
| 9/30/2020 | 90 | 11 | 15 | 21 | N/A |
| 6/30/2020 | 93 | 14 | 15 | 20 | N/A |
| 3/31/2020 | 98 | 16 | 15 | 21 | N/A |
| 12/31/2019 | 102 | 19 | 16 | 22 | N/A |
| 9/30/2019 | 103 | 20 | 15 | 20 | N/A |
| 6/30/2019 | 104 | 21 | 14 | 19 | N/A |
| 3/31/2019 | 103 | 22 | 16 | 20 | N/A |
| 1/1/2019 | 103 | 22 | 17 | 22 | N/A |
| 9/30/2018 | 101 | 22 | N/A | N/A | N/A |
| 6/30/2018 | 98 | 22 | 18 | 23 | N/A |
| 3/31/2018 | 98 | 21 | N/A | 20 | N/A |
| 12/31/2017 | 97 | 20 | N/A | 17 | N/A |
| 9/30/2017 | 94 | 19 | N/A | N/A | N/A |
| 6/30/2017 | 90 | 17 | N/A | 18 | N/A |
| 3/31/2017 | 87 | 17 | N/A | 19 | N/A |
| 12/31/2016 | 83 | 16 | N/A | 20 | N/A |
| 9/30/2016 | 79 | 15 | N/A | N/A | N/A |
| 6/30/2016 | 75 | 15 | N/A | 23 | N/A |
| 3/31/2016 | 72 | 14 | N/A | 22 | N/A |
| 12/31/2015 | 69 | 14 | N/A | 21 | N/A |
| 9/30/2015 | 67 | 14 | N/A | 19 | N/A |
| 6/30/2015 | 66 | 14 | N/A | 18 | N/A |
| 3/31/2015 | 65 | 13 | N/A | 17 | N/A |
| 12/31/2014 | 63 | 13 | N/A | 17 | N/A |
| 9/30/2014 | 62 | 13 | N/A | 16 | N/A |
| 6/30/2014 | 62 | 12 | N/A | 15 | N/A |
| 3/31/2014 | 61 | 12 | N/A | 14 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AMS's forecast earnings growth (20.8% per year) is above the savings rate (2.1%).
Earnings vs Market: AMS's earnings (20.8% per year) are forecast to grow faster than the UK market (14.8% per year).
High Growth Earnings: AMS's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: AMS's revenue (14.1% per year) is forecast to grow faster than the UK market (3.6% per year).
High Growth Revenue: AMS's revenue (14.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AMS's Return on Equity is forecast to be low in 3 years time (10.2%).
Discover growth companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 01:25 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Advanced Medical Solutions Group plc is covered by 23 analysts. 8 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Samuel England | Berenberg |
| Julie Simmonds | Canaccord Genuity |
| Keith Redpath | Cavendish |